Cargando…

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy

BACKGROUNDS: Clinical trials have demonstrated that cardiac resynchronization therapy (CRT) is effective in patients with “non-ischemic cardiomyopathy”. However, patients with dilated-phase hypertrophic cardiomyopathy (DHCM) have been generally excluded from such trials. We aimed to compare the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Min, Jin, Han, Hua, Wei, Fan, Xiao-Han, Niu, Hong-Xia, Tian, Tao, Ding, Li-Gang, Wang, Jing, Xue, Cong, Zhang, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483592/ https://www.ncbi.nlm.nih.gov/pubmed/28663761 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.04.002

Ejemplares similares

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Predictors of super-response to cardiac resynchronization therapy: the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing
por: Jin, Han, et al.
Publicado: (2017)

Predictors of non-response to cardiac resynchronization therapy implantation in patients with class I indications: the markedly dilated left ventricular end-diastolic dimension and the presence of fragmented QRS
por: Hu, Yi-Ran, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator
por: Bang, Ji Hyun, et al.
Publicado: (2015)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
por: Kuno, Toshiki, et al.
Publicado: (2017)

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
por: Obrzut, Sebastian, et al.
Publicado: (2010)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
por: El-Zarea, Gehan Abd El-Rahman, et al.
Publicado: (2016)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Repetitive optimizing left ventricular pacing configurations with quadripolar leads improves response to cardiac resynchronization therapy: A single-center randomized clinical trial
por: Gu, Min, et al.
Publicado: (2017)

Amiodarone and Catheter Ablation as Cardiac Resynchronization Therapy for Children with Dilated Cardiomyopathy and Wolff-Parkinson-White Syndrome
por: Kim, Sung Hoon, et al.
Publicado: (2013)

Epicardial Lead Placement for Cardiac Resynchronization Therapy in Dilated Cardiomyopathy Patient: Fine Tuning Anaesthetic Challenges
por: Damodaran, Srinath, et al.
Publicado: (2020)

Acute and Chronic Changes and Predictive Value of Tpeak-Tend for Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients
por: Xue, Cong, et al.
Publicado: (2016)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

A Predictive Model for Super-Response to Cardiac Resynchronization Therapy: The QQ-LAE Score
por: Liu, Xi, et al.
Publicado: (2020)

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score
por: Yang, Shengwen, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Potential value of T1 mapping in cardiac MR assessment of hypertrophic cardiomyopathy and dilated cardiomyopathy patients: preliminary results
por: Jacquier, Alexis, et al.
Publicado: (2012)

Initial Experience with MultiPoint Pacing Cardiac Resynchronization Therapy in China
por: Hua, Wei, et al.
Publicado: (2016)

Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center
por: Hu, Yi-Ran, et al.
Publicado: (2019)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

Restricted left atrial dilatation can visually differentiate cardiac amyloidosis from hypertrophic cardiomyopathy
por: Higashi, Haruhiko, et al.
Publicado: (2021)

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Prediction of Cardiac Resynchronization Therapy Response in Dilated Cardiomyopathy Using Vortex Flow Mapping on Cine Magnetic Resonance Imaging
por: Nakao, Risako, et al.
Publicado: (2019)

Echocardiographic Parameters as Predictors for the Efficiency of Resynchronization Therapy in Patients with Dilated Cardiomyopathy and HFrEF
por: Pescariu, Silvius-Alexandru, et al.
Publicado: (2021)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Dilemma with the route of venous access for hemodialysis catheter insertion in a patient with dilated ischemic cardiomyopathy treated by cardiac resynchronization therapy
por: Ashokananda, Devanahalli, et al.
Publicado: (2016)

“Burnt out” dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis
por: Sivathasan, Cumaraswamy, et al.
Publicado: (2015)

The diagnostic role of cardiac magnetic resonance used “first and last time in life” in a patient with a suspected dilated phase of hypertrophic cardiomyopathy
por: Hładij, Rafał, et al.
Publicado: (2017)

Rapid and Potent Antiarrhythmic Effect of Cardiac Resynchronization Therapy in a Patient with Advanced Dilated Cardiomyopathy and a Large Ventricular Arrhythmia Burden
por: Jeon, Dong Sub, et al.
Publicado: (2017)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d1vqg0d67r9ifphkb2sb23gl95